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CHAPTER 5 
HEALTH BOARD AREAS 
FIRST TREATMENT CONTACTS 
Chapter 4 described the situation in the Greater Dublin Area relating to the first treatment clients or 
the incidence of treated drug misuse. This chapter will deal with the situation in the health boards 
excluding the Greater Dublin area. 
During 1995 the total number of first contact clients was 491. The proportion of this group who were 
teenagers was 47 per cent and 77 per cent were under 25 years old. 
The mean age of the clients in this first contact group was 22.2 years – the mean age of males being 
21.6 years and the mean age of females was 25.0 years. On this point of age, similar age groups to 
those included in other chapters have been retained even though in the case of this first treatment 
group, the overall number can be quite small in any of the age groups, particularly the older age 
groups. The vast majority of the clients who first came for treatment in 1995 were males – 83 per cent. 
Thirteen per cent had left school before the age of 15 years and a further 19 per cent at 15 years. 
Seventy-three per cent were living with their parental family and fifty-nine per cent were unemployed 
Twelve per cent had cited their primary drug as an opiate and cannabis was the drug with the highest 
proportion of misusers (50 per cent). Stimulants accounted for 27 per cent. In this chapter, details have 
been included of the breakdown between the various health boards by the primary drug used by the 
client. 
These data for the year 1995 will be set out under the same headings as in the other chapters: 
(a) some of the socio-demographic characteristics of the clients; 
(b) aspects of their history of drug misuse; 
(c) facets of the clients’ injecting and needle-sharing practices. 
SECTION (a) – SOME SOCIO-DEMOGRAPHIC CHARACTERISTICS 
In this section the sex of the clients, their age, living status, age they left school and the level of 
education they had reached will be examined. As in the earlier chapters the employment status of the 
clients will be the last variable to be examined in this section. 
Sex 
Age is the first of the cross-tabulations by sex, followed by education, living status and employment 
status. 
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Age 
Few differences in age appeared between the sexes when one looked at the teenage group, 47 per cent 
of the males and 46 per cent of the females. However if the two oldest groups are combined, i.e. those 
over 30 years old – females were proportionately twice as likely to be in that group than were males 
(9.4 per cent of males and 20.5 per cent of females, Table 5.1). However, overall the difference 
between the sexes was significant at p<.026 level. This is reflected in the above-mentioned higher 
mean age of females. 
Table 5.1 – Age by sex 
Male Female  Total Age 
 per cent  
<15 years 3.5 2.4 3.3
15-19 years 43.8 43.4 43.7
20-24 years 31.7 21.7 30.0
25-29 years 11.6 12.0 11.7
30-34 years 4.0 4.8 4.1
35 years + 5.4 15.7 7.2
Per cent 100.0 100.0 100.0
N= 404 83 487
Missing observations=4 
Education 
Overall almost one-third of the clients had left school at or before the school-leaving age, but 
proportionately slightly more men had done so than women – 35 per cent men and 30 per cent of 
women. Differences were significant at the p<.09 level. Given that at 15 or even younger one would 
enter secondary level education it is not surprising that on the level of education reached (Table 5.3) 
no major differences were apparent between the sexes with in each case 69 per cent having some 
secondary education. Only a slightly high proportion of females (10 per cent) than males (8 per cent) 
had reached third level. 
Table 5.2 – Age left school by sex 
Male Female Total Age left school 
 per cent  
<15 years 14.4 8.5 13.5
15 years 20.2 11.9 18.9
16 years + 45.5 57.6 47.4
Still at school 19.9 22.0 20.2
Never at school 0.0 0.0 0.0
Per cent 100.0 100.0 100.0
N= 312 59 371
Missing observations=120 
 
Table5.3-Highesit level of education reached by sex 
Level of education Male Female Total 
 per cent 
Primary 4.7 2.9 4.3
Secondary 68.9 68.6 68.8
Third level 8.4 10.0 8.7
Still at school 18.0 18.5 18.2
Never at school 0.0 0.0 0.0
Per cent 100.0 100.0 100.0
N= 344 70 414
Missing observations=77 
Living status 
Approaching three-quarters (73 per cent) of the clients were living with their parental family but as 
has been found in the other chapters, proportionately fewer females than males were doing so. 
Table 5.4 – Living status by sex 
Male Female Total Living status 
 per cent  
Parental family 74.6 63.0 72.6
Partner 10.0 19.8 11.7
Institution/Homeless 2.8 1.2 2.6
Friends 3.6 2.5 3.3
Alone 5.7 11.1 6.6
Lone parent 1.3 1.2 1.3
Other 2.0 1.2 1.9
Per cent 100.0 100.0 100.0
N= 389 81 470
Missing observations=21 
A small proportion (7.3 per cent) of those in treatment for the first time in 1995 were living with other 
drug misusers. The number involved is obviously also small (32 individuals) but the interesting thing 
is that the proportion of women living with a drug user is almost double that for men – 11.8 per cent 
of women to 6.3 per cent of men. However, while there was a difference between the sexes it was not 
significant (p<.093). 
Table 5.5 – Those living with a drug misuser by sex 
Male Female  Total Living with a drug misuser 
 per cent  
Yes 6.3 11.8 7.3
No 93.7 88.2 92.7
Per cent 100.0 100.0 100.0
N= 363 76 439
Missing observations=52 
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On the living status of the small number who are living with drug misusers, we have not included a 
table here since the numbers are so small (23 men and 9 women) but for what it is worth the data 
show that men are more likely to live with their parental family than women. 
Employment 
A smaller proportion of the first treatment clients were in the unemployed group than were the total 
treatment clients, the proportion overall being 59 per cent. There was very little difference between 
men and women on this variable (Table 5.6). 
Table 5.6 – Employment status by sex 
Male Female  Total Employment status 
 per cent  
Unemployed/casual 59.2 60.5 59.4
Regular employment 20.8 16.0 20.0
Other 20.0 23.5 20.6
Per cent 100.0 100.0 100.0
N= 390 81 471
Missing observations=20 
Age 
On the crosstabulation of age with education, age left school and level of education reached were 
considered. Tables 5.7 and 5.8 give the details here. It was pointed out earlier that all the table 
breakdowns in each chapter would be kept similar to facilitate comparison, but for this variable, 
because of the small numbers in the 30 plus age category (30 clients) they will be combined only in 
the text combined doing a separate calculation which showec that 30 per cent had left school before 
the age of 15 and a further 13 per cent had left at the official minimum school leaving age. 
The vast majority of the clients had had some secondary education, but as usual with the data on this 
question, the likelihood of clients having some level of secondary education was large anyway. For 
the available data, the difference on these two crosstabulations was significant (p<.000). 
Table 5.7- Age left school by age 
<15 15-19 20-24 25-29 30-34 35+ Total Age left school 
   per cent    
<15 years 18.8 10.3 11.2 18.6 53.8 11.8 13.5
15 years 0.0 17.8 25.2 18.6 7.7 17.6 18.9
16 years + 0.0 37.4 62.6 62.8 38.5 70.6 47.6
Still at school 81.2 34.5 1.0 0.0 0.0 0.0 20.0
Never at school 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 16 174 107 43 13 17 370
Missing observations=121 
 
 
 
Table 5.8 – Highest level of education reached by age 
<15 15-19 20-24 25-29 30-34 35+ Total Level of education 
   per cent    
Primary 6.3 3.2 3.9 2.3 15.4 13.0 4.4
Secondary 12.5 59.8 83.5 93.2 76.9 52.2 68.9
Third level 0.0 5.3 11.8 4.5 7.7 34.8 8.7
Still at school 81.2 31.7 0.8 0.0 0.0 0.0 18.0
Never at school 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 16 189 127 44 13 23 412
Missing observations=79 
Living status 
Again while the vast majority of the clients (73 per cent) were living with their parental family, this 
was a larger proportion than that for the total treatment group. This was not surprising since the mean 
age of the first treatment group was lower than that of the total treatment group. However, again living 
status was very much age dependent as may be seen from Table 5.9. 
Table 5.9 – Living status by age 
<15 15-19 20-24 25-29 30-34 35+ Total Level of education 
   per cent    
Parental family 87.4 91.9 73.5 43.4 36.8 11.4 72.6
Partner 0.0 0.5 7.4 28.2 42.1 57.0 11.5
Institution/Homeless 12.6 1.5 1.4 7.6 0.0 2.9 2.6
Friends 0.0 1.4 6.6 5.7 0.0 2.9 3.4
Alone 0.0 1.4 8.2 13.2 15.8 20.0 6.6
Lone parent 0.0 1.0 0.7 1.9 5.3 2.9 1.3
Other 0.0 2.3 2.2 0.0 0.0 2.9 2.0
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 16 209 136 53 19 35 468
Missing observations=23 
Employment 
Where clients were unemployed, while the overall proportion was 60 per cent, the highest proportion 
was in the 25-29 year age group at 82 per cent. 
Table 5.10 – Employment status by age 
<15 15-19 20-24 25-29 30-34 35+ Total Employment status 
   per cent    
Unemployed/casual 6.7 51.0 67.6 81.8 70.0 58.8 59.5
Regular employment 0.0 15.5 26.6 18.2 25.0 29.4 20.0
Other 93.3 33.5 5.8 0.0 5.0 11.8 20.5
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 15 206 139 55 20 34 469
Missing observations=22 
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SECTION (b) – ASPECTS OF THE CLIENTS’ HISTORY OF DRUG MISUSE 
Primary drug of misuse 
Attention will now be drawn to the clients’ history of drug misuse. The main crosstabulations will be 
by sex and age and we first consider the sex differences in the primary drug of misuse. With regard to 
opiates, there were clear differences between men and women. Proportionately more women than men 
who were in treatment cited an opiate as their primary drug (Table 5.11). This table also shows that 
the other main difference between the sexes was in the misuse of cannabis – proportionately twice as 
many men as women were involved with these drugs. Females were more likely to have a stimulant or 
an hypnotic or sedative as their primary drug than were males. The differences were significant at the 
p<000 level. 
Table 5.11 – Primary drug of misuse by sex 
Primary drug Male Female Total 
 per cent
Opiates/Opioids 10.9 20.0 12.5
Stimulants 25.4 33.3 26.8
Hypnotics/Sedatives 2.5 11.9 4.1
Hallucinogens 4.4 2.4 4.1
Volatile inhalants 2.0 2.4 2.0
Cannabis 54.8 27.4 50.1
Other 0.0 2.4 0.4
Per cent 100.0 100.0 100.0
N= 405 84 489
Missing observations=2 
In considering the age breakdown for this group of first contact clients, cannabis was the most likely 
primary drug and in all the age groups except for the over 35s where the most likely primary drug was 
either a hypnotic or a sedative. Caution must be exercised here in that the numbers in this older age 
groups for the first treatment clients were small but as was mentioned earlier, the age groups were 
retained to keep them in line with the analysis in the other chapters where the numbers were much 
greater. If the two oldest groups are combined, the picture shows a lower proportion of cannabis 
misusers (35 per cent) than in the other groups with 31 per cent of hypnotic/sedative misusers and 26 
per cent misusing opiates. Retaining the original breakdown by age, the difference here between the 
particular drug cited as a primary drug and the age of the client was significant (p<.000). 
Table 5.12 – Primary drug of misuse by age 
<15 15-19 20-24 25-29 30-34 35+ Total Primary drug 
per cent   
Opiates/Opioids 0.0 8.0 14.4 13.9 35.0 20.0 12.3
Stimulants 6.2 34.3 29.5 17.2 5.0 8.5 26.9
Hypnotics/Sedatives 0.0 0.0 0.7 3.4 0.0 48.6 4.1
Hallucinogens 0.0 5.2 4.0 5.2 0.0 0.0 4.1
Volatile inhalants 25.0 2.2 0.0 1.7 0.0 0.0 2.0
Cannabis 68.8 49.8 51.4 58.6 60.0 20.0 50.2 
Other 0.0 0.5 0.0 0.0 0.0 2.9 0.4 
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
N= 16 213 146 58 20 35 488 
Missing observations=3 
 
As with the total treatment group, significant differences were shown between the age the client left 
school and the primary drug of misuse. Table 5.13 shows that while cannabis was most likely to be 
cited as the primary drug in all the age groups, proportionately more of those who had left school at 15 
years or under used an opiate as their primary drug. Those who had left school at 16 years or over or 
were still at school were least likely to mention an opiate. Half of the 16 years plus group and 61 per 
cent of the ‘still at school’ group cited cannabis. 
Table 5.13 – Primary drug by age left school 
Primary drug <15 15 years 16 years+ Still at 
school 
Total 
 per cent 
Opiates/Opioids 25.5 27.1 11.4 1.3 14.2
Stimulants 31.4 17.1 30.7 22.7 26.6
Hypnotics/Sedatives 2.0 1.4 4.0 0.0 2.4
Hallucinogens 2.0 5.7 4.0 2.7 3.8
Volatile inhalants 0.0 1.4 0.0 10.7 2.4
Cannabis 39.2 45.7 50.0 61.3 50.0
Other 0.0 1.4 0.0 1.3 0.5
Percent 100.0 100.0 100.0 100.0 100.0
N= 51 70 176 75 372
Missing observations=119 
Table 5.14 has details of the breakdown for the most commonly used primary drug and this table 
shows that, as noted earlier, cannabis was the most common with 50 per cent of the clients citing 
cannabis as their primary drug. The second most common was ecstasy named by 26 per cent of the 
clients. The proportion citing heroin or another opiate was 12 per cent and the various other smaller 
proportions by drug are listed. 
Table5.14 – Most commonly used primary drug 
Drug Percentage N 
Heroin 11.0 54 
Other opiates 1.4 7 
Cannabis 50.1 246 
Ecstasy 25.6 125 
Cocaine 0.9 4 
Amphetamines 0.4 2 
Other stimulants 0.2 1 
Benzodiazapines 1.4 7 
Other hypnotics/sedatives 2.6 13 
LSD 3.0 14 
Other hallucinogens 1.0 6 
Volatile inhalants 2.0 10 
Other 0.4 2 
Totals 100.0 491 
Again in this chapter we will look in some brief detail of the clients who named ecstasy as their 
primary drug. 
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The age range was from 14 years (1 client) to 35 years (2 clients) but the age group with the largest 
proportion of the clients (58 per cent) was the 15 to 19 year olds. Some 33 per cent were aged between 
20 and 24 years old and this means that 91 per cent of the clients who named ecstasy as their primary 
drug were aged between 15 and 24 years old. The proportion of females was 21 per cent which is 
somewhat higher than the proportion of 17 per cent in the first treatment population. 
Health Board breakdown by primary drug 
It was stated at the outset of this chapter that breakdowns for particular health boards would be 
undertaken by primary drug and here the proportions of clients who had cited particular primary drugs 
in the different health board areas are set out. The Eastern Health Board area, which as noted earlier, 
includes part of Dublin outside the Greater Dublin area and also Wicklow and Kildare, showed that 
the highest proportion of the clients named an opiate as their primary drug. Cannabis had the highest 
proportion as a primary drug in four of the other health boards. However, clients in the North-Eastern 
Health Board area were most likely to have said that a stimulant was their primary drug. As has been 
shown on Table 5.14 this was most likely to have been ecstasy. 
The small numbers in some of the areas make percentage data problematic. However, the frequencies 
on the variables are included in Appendix B. 
Table 5.15 – Primary drug of misuse by health board area 
Rest of EHB SHB SEHB MWHB MHB NEHB NWHB WHB Primary drug 
 per cent   
Opiates/Opioids 43.9 2.5 0.0 9.7 6.5 25.0 15.4 25.0
Stimulants 19.8 29.1 15.9 38.7 29.0 57.1 30.8 0.0
Hypnotic/Sedatives 3.3 7.4 0.0 0.0 0.0 0.0 7.7 25.0
Hallucinogens 4.4 4.8 3.4 6.5 0.0 0.0 0.0 0.0
Volatile Inhalents 0.0 2.0 3.4 0.0 9.7 0.0 0.0 0.0
Cannabis 27.5 54.2 77.3 45.2 54.8 17.9 38.5 50.0
Other 1.1 0.0 0.0 0.0 0.0 0.0 7.7 0.0
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 91 203 88 31 31 28 13 4
Age first used primary drug 
The differences between the sexes on the age they had first used their primary drug were significant 
(p<000). If one looks at the teenage group here, it is obvious that males had a higher proportion of 
misusers than had females. Table 5.16 shows that 83 per cent of males were teenagers when they first 
used in contrast with 62 per cent of females. These differences are obviously compensated for in the 
proportions in the 20 to 24 year old group and the 25 years plus, where proportionately there were 
twice as many women as men. 
Table 5.16- Age first used primary drug by sex 
Male Female Total Age first used 
 per cent  
<15 years 22.6 8.9 20.2
15-19 years 60.6 53.2 59.4
20-24 years 10.6 22.8 12.7
25 years + 6.2 15.1 7.7
Per cent 100.0 100.0 100.0
N= 376 79 455
Missing observations=36 
 
There was a wide spread of age first used when one looked at this cross-tabulation but, as would be 
expected, those in the older age groups were most likely to have been older at age first used (Table 
5.17). 
Table 5.17 – Age first used primary drug by age 
<15 15-19 20-24 25-29 30-34 35+ Total Age first used 
   per cent    
<15 years 100.0 28.3 11.6 7.0 10.6 0.0 20.0
15-19 years 0.0 71.7 65.9 54.4 36.8 11.8 59.3
20-24 years 0.0 0.0 22.5 35.1 15.8 11.8 12.7
25 years + 0.0 0.0 0.0 3.5 36.8 76.4 7.7
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 16 191 138 57 19 34 455
Missing observations=36 
While those whose primary drug was an opiate were most likely to have used as a teenager, 
proportionately more of those whose primary drug was either a stimulant or cannabis were using as 
teenagers (see Table 5.18). Again as noted earlier, the problem arises of making meaningful comment 
on small numbers 
Table 5.18 – Age first used by primary drug by primary drug 
Age first used Opiates/
Opioids 
Stimul-
ants 
Hypnotics
Sedatives
Hallucin-
ogens 
Cannabis Other Total 
    per cent    
<15 years 5.2 9.5 0.0 23.5 29.6 60.0 20.1
15-19 years 44.8 73.0 10.0 58.8 61.5 30.0 59.5
20-24 years 29.3 14.3 20.0 17.6 7.1 0.0 12.7
25 years+ 20.7 3.2 70.0 0.0 1.8 10.0 7.7
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 50 126 20 17 226 10 457
Missing observations=34 
Duration of use of primary drug 
Duration of use was included in the commentary on sex and age but we will now look separately at 
duration of use of primary drug by primary drug. Hypnotics and sedatives had the highest proportion 
with the longest duration of use. Sixty-eight per cent of those using these drugs had used them for 10 
years or more. Here again, of course, one runs into the problem of numbers – only 19 clients were in 
this category anyway. Overwhelmingly in the case of all the other groups of drugs, the most likely 
duration was 3 years or less. In particular where opiates were concerned, the most likely duration of 
use was 2-3 years, and similarly for the proportions using stimulants and cannabis, the most likely 
duration was 2-3 years (Table 5.19). 
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Table 5.19 – Duration of use of primary drug by primary drug 
Duration of use Opiates/
Opioids 
Stimul-
ants 
Hypnotics
Sedatives
Hallucin-
ogens 
Cannabis Other Total 
    per cent    
One year or less 26.3 38.8 0.0 31.2 24.5 77.8 29.0
2-3 years 42.1 40.5 15.8 43.8 35.6 11.1 36.8
4-5 years 12.3 14.9 15.8 0.0 14.8 0.0 13.7
6-9 years 7.0 5.8 0.0 25.0 15.7 11.1 11.4
10 years + 12.3 0.0 68.4 0.0 9.4 0.0 9.1
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 57 121 19 16 216 9 438
Missing observations=53 
Some small differences occurred between males and females on the duration of use of their primary 
drug with a slightly higher proportion of females having the lowest duration (one year or less) but the 
majority of both sexes – 65 per cent of males and 67 per cent of females were using for less than 3 
years. 
Table 5.20 – Duration of use of primary drug by sex 
Duration Male Female Total 
 per cent 
One year or less 27.9 35.1 29.1
2-3 years 37.3 32.4 36.5
4-5 years 14.9 8.1 13.8
6-9 years 12.4 6.8 11.5
10 years+ 7.5 17.6 9.2
Per cent 100.0 100.0 100.0
N= 362 74 436
Missing observations=55 
It would seem from the evidence of Table 5.21 that as could be expected, age did have an influence on 
the duration of use of the primary drug in that the older the client, the longer the duration of use. 
Table 5.21 Duration of use of primary drug by age 
<15 15-19 20-24 25-29 30-34 35+ Total Duration 
   per cent    
One year or less 86.7 47.0 13.5 9.3 11.1 3.2 28.9
2-3 years 6.7 48.1 41.4 14.8 11.1 16.1 36.7
4-5 years 6.7 4.3 24.8 18.5 11.1 19.4 13.8
6-9 years 0.0 0.5 19.5 31.5 22.2 6.5 11.5
10 years+ 0.0 0.0 0.8 25.9 44.4 54.8 9.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 15 185 133 54 18 31 436
Missing observations=55 
 
Frequency of use of primary drug 
The difference between the sexes on the frequency of use was not significant (p<.211) even though 
Table 5.22 shows that proportionately close on twice as many women as men used their primary drug 
once per week or less and proportionately fewer women were in the more frequent user categories. 
Table 5.22 –Frequency of use of primary drug by sex 
Frequency of use Male Female  Total 
 per cent 
Once per week  9.3 17.0 10.6
2-6 days per week 40.9 35.4 39.9
Daily 37.8 36.6 37.6
Drug free 12.0 11.0 11.9
Per cent 100.0 100.0 100.0
N= 389 82 471
Missing observations=20 
Turning to age. Table 5.23 demonstrates that while almost half (48.4 per cent) of teenagers were using 
2-6 times per week, the older age groups were using more frequently. The differences here were 
significant (p<.000). 
Table 5.23 – Frequency of use of primary drug by age 
<15 15-19 20-24 25-29 30-34 35+ Total Frequency of use 
   per cent    
Once per week 26.7 14.4 9.0 1.8 10.5 2.9 10.7
2-6 days per week 53.3 48.0 39.2 31.0 21.1 17.1 40.1
Daily 13.3 26.7 37.8 54.5 57.9 74.3 37.7
Drug free 6.7 10.9 14.0 12.7 10.5 5.7 11.5
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 15 202 143 55 19 35 469
Missing observations=22 
For those who injected their primary drug, the frequency of use was most likely to be daily. However, 
the number of injectors was very small for this first treatment group. In the largest group, those who 
smoked their primary drug, almost half of that group smoked on a daily basis. 
Table 5.24 – Frequency of use by route of administration of primary drug 
Inject Smoke Eat/Drink Sniff Total Frequency of use 
   per cent  
Once per week 3.6 10.5 11.4 18.2 10.6
2-6 days per week 14.2 31.8 56.0 45.4 40.0
Daily 64.3 48.0 18.9 18.2 37.5
Drug free 17.9 9.7 13.7 18.2 11.9
Per cent 100.0 100.0 100.0 100.0 100.0
N= 28 258 175 11 472
Missing observations=19 
Route of administration of primary drug 
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When one looked at route of administration of primary drug by primary drug, an almost similar 
proportion of those using an opiate (46 per cent) injected their primary drug as smoked it (49 per 
cent). As would be expected, the vast majority of those who used cannabis smoked that drug (97 per 
cent). 
Table 5.25 – Route of administration of primary drug by primary drug 
Route Opiates/
Opioids 
Stimul-
ants 
Hypnotics
Sedatives
Hallucin-
ogens 
Cannabis Other Total 
    per cent    
Inject 45.9 0.0 0.0 0.0 0.0 0.0 5.7
Smoke 49.2 2.3 0.0 0.0 97.2 0.0 55.4
Eat/Drink 4.9 96.2 100.0 100.0 2.8 16.7 36.5
Sniff 0.0 1.5 0.0 0.0 0.0 83.3 2.4
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 61 132 20 20 246 12 491
Missing observations=0 
In the following table (Table 5.26) it may be seen that while men were most likely to smoke their 
primary drug, women were most likely to use the route of eating or drinking. The difference between 
the sexes was significant at the p<.002 level. 
Table 5.26 – Route of administration of primary drug by sex 
Route of administration Male Female Total 
 per cent 
Inject 5.2 8.3 5.7
Smoke 59.3 36.9 55.4
Eat/Drink 33.0 52.4 36.4
Sniff 2.5 2.4 2.5
Per cent 100.0 100.0 100.0
N= 405 84 489
Missing observations=2 
If age by route of administration is checked, since the majority of the clients were smoking their 
primary drug anyway, that route of administration showed up as representing the majority of the 
clients’ preferred route, except in the oldest age group where the clients were most likely to eat or 
drink their primary drug (Table 5.27). The differences between the age and the route of administration 
were significant at the p<.000 level. Again the small numbers in the older age groups must be noted. 
Table 5.27 -Route of administration of primary drug by age 
Route of administration <15 15-19 20-24 25-29 30-34 35+ Total 
    per cent    
Inject 0.0 2.8 6.2 8.6 20.0 8.6 5.5
Smoke 62.5 52.6 59.6 67.3 65.0 28.5 55.5
Eat/Drink 12.5 42.3 33.6 20.7 15.0 62.9 36.5
Sniff 25.0 2.3 0.6 3.4 0.0 0.0 2.5
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 16 213 146 58 20 35 488
Missing observations=3 
 
SECTION (c) – INJECTING AND NEEDLE-SHARING PRACTICES 
Currently injecting 
A small number of clients were injecting – 14 males and 4 females. Only small proportionate 
differences appeared between the sexes on the percentages of each sex currently injecting (Table 
5.28). 
Table 5.28 – Currently injecting by sex 
Currently injecting Male Female Total 
 per cent 
Yes 3.6 4.8 3.8
No 96.4 95.2 96.2
Per cent 100.0 100.0 100.0
N= 391 84 475
Missing observations=16 
When currently injecting by age was examined, the problem of the small numbers was again evident 
(18 persons) and all that could be said was that there might be some slight evidence that increasing 
age meant a greater likelihood that a person would be currently injecting. 
Of those who were currently injecting, only five people (four males and one female) were currently 
sharing so a table to look at the differences would not be very useful. 
Secondary drug of misuse 
Here the liklihood of the client using more than their primary drug will be examined and in this case 
some 79 persons or 17 per cent had not used any secondary drug. Where information was available 
that a secondary drug had been used, it may be seen that cannabis was the most commonly used 
secondary drug for this group (103 cases 27 per cent). The next most likely secondary drug was 
alcohol with 99 cases or 26 per cent. Stimulants had almost very similar numbers and proportions -97 
persons or 25 per cent. As these data indicate, these three categories of drugs accounted for the vast 
majority of the secondary drug use. The only other drug to feature was hallucinogens with 16 per cent 
of the clients citing it. Opiates only accounted for 3 per cent. 
Where a second secondary drug was concerned, in total 219 clients were not using a second secondary 
but 193 clients were. Alcohol and stimulants were the most likely to be cited where there was 
information that a second secondary drug was involved – 26 per cent in each case. The proportion 
citing an hallucinogen was close behind with 23 per cent. Cannabis was the fourth most likely to be 
cited with 16 per cent of those who had used a second secondary drug citing cannabis. Thus these four 
drug categories covered most of the cited second secondary drug misuse. Opiates were only 
mentioned by 3 per cent of the clients as a second secondary drug. 
Age first used any drug 
As with the other groups it was clear that the vast majority of the clients had first used any drug 
excluding alcohol before the age of 20 – 89 per cent in this case. Approaching one-third (32 per cent) 
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were younger than 15 years old and a further 57 per cent were aged between 15 and 19 years old when 
they first used any drug. As already mentioned, the name of the drug involved was not noted. 
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CHAPTER 6 
REVEALED DIFFERENCES BETWEEN NUMBERS 
IN TREATMENT IN THE GREATER DUBLIN AREA 
AND THE HEALTH BOARD AREAS 
Since combining the figures of clients in treatment for Ireland as a whole only serves to disguise the 
dominance of the Dublin data, no general analysis for Ireland will be undertaken. Instead in this 
chapter, in order to emphasise the difference between the two areas, some frequency data will be set 
out separately for Dublin and the other areas combined. The data on the total treatment group (Figures 
6.1 to 6.12) will first be considered and then the data on the first treatment clients (Figure 6.1A-
6.12A). 
Total Treatment clients 
In examining the socio-demographic data for the total treatment group it will be seen that the sex 
ratios were slightly more pronounced than in the other health board areas. In Dublin the ratio of males 
to females was 78:22 while in the rest of the country, there was a larger proportion of males 83:17 (see 
Figure 6.1). 
Looking at age, the mean age of the two groups was similar – 23.6 for Dublin, 23.7 for the other 
health boards. However, outside Dublin the mean age of the females is a great deal higher than that of 
females in the Dublin area. This latter was 26.7 years in contrast to 23.2 years in Dublin (Figure6.2). 
The difference between the two groups in the proportions leaving school at age 15 or under was quite 
dramatic (Figure 6.3). In the Dublin area adding the proportions in the two age groups it was around 
60 per cent for both males and females. For the other health boare areas there was both a large 
difference between the proportions of males and females leaving at or before the official school 
leaving age and also a quite different picture from the Dublin data. Forty per cent of males and 28 per 
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cent of females had left school at 15 years or under. Another interesting finding here was the 
difference in the proportions still in education. In Dublin it was 3 per cent while outside of Dublin, it 
was 12 per cent. 
Turning to living status now, fairly similar proportions of clients were still living with their parental 
family as defined. Seventy-one per cent in Dublin and 67 per cent in the rest of the country and there 
were no real differences between males and females here. Where data on employment status were 
examined, a difference between the two groups was apparent. For Dublin, the proportion unemployed 
 
 for both males and females and overall was 87 per cent. This contrasted with an overall proportion of 
66 per cent for the group from the other health board areas and for both males and females. No figures 
have been included here for living status or employment status since the proportions of those living 
with their parental family and those unemployed were extremely high. 
Moving on now to compare the history of drug misuse of both groups. In looking at the primary drug 
of misuse, the difference between the two sets of populations was quite dramatic. Figure 6.4 
demonstrates the clear difference in the breakdowns for opiates, cannabis and stimulants. 
However, if one looks at the age the clients first used their primary drug (Figure 6.5), there were 
evident differences here with proportionately more of those outside Dublin being under 15 years old at 
first use. Eight per cent of those in Dublin had first used at under 15 years old, while the proportion in 
this age group in the rest of the country was 19 per cent. However, if we take the proportion of those 
who were teenagers when they first used, the proportions in the two areas are much closer with only 
slightly more (74 per cent) of those in the other health boards being teenagers in contrast to 73 per 
cent in Dublin (see Figure 6.5). 
 
Coming to the duration of use of the primary drug there were few differences in the duration of use 
between the two areas. Figure 6.6 indicates this. 
Where frequency of use was concerned, it was apparent that proportionately daily use was more 
frequent in the Dublin population than the rest of the country, although the proportions who were drug 
free were similar in both areas (Figure 6.7). 
 21 
  
In looking at the route of administration of primary drug, the results here must be put in the context of 
the proportions in each area whose primary drug was an opiate. In other words. Figure 6.8 reflects the 
preponderance of opiate users (whose most likely route of administration would be to inject) in the 
Dublin area and the proportionately higher number of cannabis users (who would be more likely to 
smoke their primary drug) in the other areas. 
 
Again a similar reflection may be seen in Figure 6.9 where the proportions of those currently injecting 
are shown. The differences in the proportions using opiates is again pointed up here by the proportions 
injecting, which in Dublin far exceeded the proportion of those injecting in the rest of Ireland. 
 
  
Of those in either of the two areas who were currently injecting, similar proportions were currently 
sharing. 
Some differences between the sources of referral to treatment of the clients in Dublin and elsewhere 
were apparent as Figure 6.11 shows. While people in both areas were most likely to be referred by 
themselves or their family or friends, this was more apparent in Dublin and proportionately more 
clients outside of Dublin were referred by the courts, probation or police and also by general 
practitioners. 
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 A question was asked about the age the clients had first used any drug (excluding alcohol) and Figure 
6.12 shows that there was no difference between the Dublin and rest of Ireland clients, the teenage 
years were the most likely age at which they would first use any drug. 
First treatment clients 
Coming to the first treatment clients now and the first variable examined is that of sex. Again the 
enormous difference between the proportions of men and women in the two areas is pointed up with a 
similar picture to the total treatment group but a slightly higher proportion of males to females in the 
areas outside Dublin. 
 
In Figure 6.2A, the difference in the mean ages of the two groups is apparent. The first treatment 
clients in Dublin have a somewhat younger mean age than those outside of Dublin and this was 
particularly true of the females. 
 
 The age at which the clients had left school is the subject of Figure 6.3A and shows that the first 
treatment clients in Dublin were more likely to leave school earlier than were the clients in other 
areas. This was true for both males and females. Also a higher proportion of these latter clients were 
still at school. 
 
When the data on the type of primary drug of misuse were examined the preponderance of opiates was 
again evident in the group from Dublin centres and in the rest of the country the two highest 
proportions of clients named cannabis and stimulants (Figure 6.4A). 
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 Turning to age at which the client first used their primary drug, a somewhat higher proportion of the 
clients outside Dublin had first used at under 15 years while this was counterbalanced by the higher 
proportion of Dublin clients first using in the age group 15 to 19 years old. If the two groups of 
teenagers are combined, the proportions in Dublin and the other areas were similar. 
 
 
Figure 6.6A shows the duration of use of the primary drug and indicates that proportionately the 
Dublin clients had shorter duration of use before coming for treatment. 
 
Seeing that duration of use of primary drug for the first treatment clients outside of Dublin was longer 
than for the Dublin group, the frequency of use of primary drug would appear to have been lower in 
the rest of Ireland group as Figure 6.7A shows. 
 
Given the proportionate differences in the type of primary drug, it was not surprising that there were 
distinct differences between the two areas in the proportions of those injecting when route of 
administration of the primary drug was examined. However, in both cases the most likely route of 
administration of the primary drug was smoking. Figure 6.8A has the details. 
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Again the type of primary drug has to be kept in mind when the proportions of those currently 
injecting are examined. As would be expected, there was a far higher proportion of injectors in Dublin 
than in the other areas and the contrast is shown on Figure 6.9A. 
Turning to those who were currently injecting the proportions of those sharing in each area are 
displayed on Figure 6.10A. It is evident that the Dublin injectors are more likely to share than the 
clients from other areas – almost a quarter of the Dublin group and only 5 per cent of the other group 
of those currently injecting are said to have shared in the past month. 
 
 
As regards the source of the referral of the clients, again as with the total treatment group the most 
likely source of referral in each area was the client themselves or their family or friends. While the 
proportions were the highest from that source for both areas, the proportion for Dublin was higher 
than in other areas. While the proportions who were referred by courts, probation or police were 
similar, clients in the areas outside of the Greater Dublin area were more likely to have been referred 
from general practitioners or hospitals or other medical sources (Figure 6.11 A). 
Looking at the last figure here, this examines the age the client had used any drug except alcohol and 
here it may be seen that there were no real differences between the two groups. Both were 
overwhelmingly most likely to have first used any drug while they were teenagers. 
 
 Main points arising 
It is abundantly clear from these data that in certain areas there are crucial differences between the 
populations in treatment in Dublin and outside of Dublin. This is true both for the total treatment 
population and for the first treatment group. These differences are most notable in mean age of males 
and females, in age left school, primary drug with the consequent difference in route of administration 
of primary drug and finally in the frequency of use of primary drug. This would indicate that the 
profile of the drug misuser in treatment in the Greater Dublin Area is quite different from that of the 
drug misuser in treatment in the other areas in Ireland. As was found in earlier reports for Dublin, the 
profile of the drug misuser in treatment is that of a young, unemployed male who had left school early 
and was misusing an opiate, most likely to be heroin, possibly injecting it. However, the profile of the 
drug misuser outside of Dublin is more difficult to define. The one exception here is that he is most 
likely to be male, but he is younger than his Dublin counterpart, less likely to have left school early or 
to be unemployed at present. He is also a great deal more likely to be a cannabis user or ecstasy user 
and it would follow that he would either smoke cannabis or take ecstasy. He is somewhat more likely 
to have first used his primary drug at a younger age but to use less frequently than his Dublin 
counterpart. 
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CHAPTER 7 
CONCLUDING COMMENTS 
This final chapter will look at some of the more important findings in the Report relative to the issues 
which arise in the area of drug misuse in Ireland. It should be remembered that the data here are for 
1995 and concentration will be on the situation during that year. Data were received from the 
treatment centres in the Greater Dublin area and the health board areas outside the GDA listed in 
Appendix A. As in previous reports, these data refer to those problem drug users who present for 
treatment rather than all those who have drug problems or indeed all of those who use drugs. 
As already explained elsewhere in the Report, the preponderance of the numbers of clients in Dublin 
would skew any general comments on Ireland in most of the findings since a clear picture of the 
differences between the results from the Greater Dublin Area and the other areas emerged. On this 
point Hartnoll (1995, p.65), for instance, remarks that surveys of drug use show higher prevalence 
rates for illegal drugs in urban than in rural areas. 
Focussing first then on the Greater Dublin area and looking briefly at the main results emerging, based 
on experience in earlier reports (for instance, O’Higgins, 1996) we have come to expect a rise in the 
numbers in treatment, both of those who have been in treatment and the number of those who have 
come for the first time during 1995. This was indeed the case and a rise of 21 per cent for the total 
treatment group was noted with a similar rise for the first treatment group. The increasing provision of 
services undoubtedly has contributed to the increase in the numbers being treated since places must be 
available before treatment can start. However, since there is no way of knowing precisely whether 
there are hidden increases and if so, what is the extent of them, the data from the reporting system is at 
present the best available indicator of the rise in prevalence and incidence. The estimated rates for 
treated drug misuse for the Dublin area show a rise in the rate from 7.1 in 1994 to 8.9 per thousand in 
1995 for total treatment clients and from 3.0 per thousand to 3.6 per thousand persons aged between 
15 and 39 years old for first treatment contacts (Appendix D). 
As regards the age of the clients, while the mean age of the clients overall had fallen slightly, for 
males the mean age had remained the same but for females it had fallen by 1.2 years. The majority of 
both sexes (65 per cent) were under 25 years old and this was an increase of 4 per cent over 1994 in 
this age group. Isolating the first treatment group, the mean age was 20.7 years – the mean age of the 
males being 20.8 years and of the females, 20.5 years. In this case 84 per cent of the clients were 
under 25 years old. 
Reports in earlier years found that proportionately more women were likely to be living with a partner 
who was a drug misuser and the data in this report show that proportionately more women than men 
were living with drug misusers. 
One of the striking features identifiable in these data is the ever-present high levels of unemployment 
among the drug misusers relative to those found in the population in general (see, for instance, Labour 
Force Survey, 1995). These levels have held for the six years of the reporting system (1990-1995). It 
was argued earlier in this Report that it is difficult to know whether these inordinately high 
proportions are comparable to rates in the areas of residence of the clients anyway but, on the face of 
it, unemployment at an 80 per cent level would seem to indicate that drug misusers are more likely to 
be unemployed whatever their area of residence. This is, of course, a situation where it is difficult to 
assess whether people are unemployed because they are drug misusers or whether unemployment was 
a contributory factor to their being drug misusers. Another constant finding in the Dublin data is that 
of generally low education levels in comparison with the general population (see, for instance, 
 
O’Higgins 1996a p.80) being again evident in 1995. However, there is also evidence of a lowering of 
the proportion leaving school at or before the school-leaving age which obviously has led in turn to 
higher participation rates at secondary school level. 
Opiates continued to be the drug groups for which most of the clients in the Greater Dublin area 
sought treatment. When reference is made to opiates, the data show that heroin was the most likely 
opiate to have been used. In 1995 the proportion of those clients naming an opiate as their primary 
drug was 87 per cent and this was a slightly larger proportion than for 1994 where 83 per cent of the 
clients cited an opiate. Isolating the proportions for the first treatment group, 77 per cent cited an 
opiate in 1995 compared to 74 per cent in 1994. Thus there was some evidence here of a rise in the 
proportions in treatment for opiate misuse. Associated with this finding was that the proportion of 
those who were injecting their primary drug was lower in 1995 than for the previous year – 53 per 
cent in contrast to 60 per cent in 1994 and the proportions who smoked their primary drug had 
increased by 9 per cent. Taking the first treatment group separately, a similar reduction in the 
proportions injecting was to be seen in the first treatment group with a reduction of 17 per cent in the 
proportion injecting their primary drug and an increase of 18 per cent in those smoking. Therefore 
while the proportion of opiate users increased the proportion injecting opiates appeared to have 
decreased and the proportion of smokers increased. 
Given the high profile of the drug ecstasy and the concern which has arisen about its consumption, 
some breakdown by age and sex was undertaken. Overall the number and proportion of those using 
ecstasy was 107 or 3 per cent of the total treatment clients in the Greater Dublin area and isolating the 
first treatment clients from that group 84 of them or 6 per cent named ecstasy. The results of the age 
breakdown were not surprising in that over half of the clients were aged between 15 and 19 years old 
with the second highest proportions being in the 20-24 year old age group. Thus around 90 per cent 
were recorded as being aged between 15 and 24 years old. Females were proportionately more likely 
than would be expected, given their proportion in the population of the treated drug misusers, to name 
ecstasy as their primary drug. For instance, in the total treatment group 27 per cent of those naming 
ecstasy were female as against 22 per cent being female in that group. When we separated out the first 
treatment clients, the difference in the proportion was even greater, 30 per cent of the group naming 
ecstasy as their primary drug were females in contrast to a proportion of 21 per cent of that first 
treatment group being female. 
The age at which the client had first used his/her primary drug of misuse was between 15 and 19 years 
old and this drug was most likely to have been an opiate. If the client was in the under 15 year old 
group when first using, he or she was most likely to have used cannabis. 
So for the Dublin data, the most likely profile of the drug misuser being treated for drug misuse 
persists as the young, unemployed male, living in a deprived area and misusing heroin. There is some 
evidence of a behaviour change as regards the route of administration of the primary drug in that 
smoking, rather than injecting, seems to be on the increase. 
As was reported earlier, the data for the areas outside of the GDA show some quite different results to 
the Dublin data. Going through the main findings for the other areas there are of course no previous 
data available to facilitate comparisons with earlier years. Firstly, it was found that the overwhelming 
majority of the clients were males. The mean age for males was 23 years and females were somewhat 
older with a mean age of 26.7 years. Isolating the first treatment group, the clients were younger – 
21.6 years for males and females were older than their male counterparts at 25 years old. Over two-
thirds were living with their parental family and if first treatment contact clients are taken separately 
an even higher proportion of them were living in similar circumstances (73 per cent). 
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Unemployment levels among the clients here were extremely high – overall 66 per cent of all the 
clients and separating the first contact group, although still relatively high, a smaller proportion – 59 
per cent – of the first treatment group were unemployed. 
The estimated rates for treated drug misuse for each of the Health Boards outside Dublin are shown in 
Appendix D. The Southern Health Board shows the highest rates for total treatment clients and also 
when the rates for first treatment clients are examined separately. The Western Health Board shows 
the lowest rates indicating that the lowest returns were from that Health Board. 
Cannabis was the drug group with the highest proportion of misusers in treatment with stimulants 
(mainly ecstasy) coming next. It follows that a majority of the clients either smoked or used their 
primary drug orally. As regards age at first use the vast majority of clients were less than 20 years old 
when they first used. 
The breakdown of the figures on the number and proportion of clients naming ecstasy as their primary 
drug for the health boards outside the GDA showed that the number and proportion was 178 or 22 per 
cent of the total treatment clients and isolating the first treatment clients the number was 125 or 25 per 
cent of them. Over half (54 per cent) of the total treatment group were aged between 15 and 19 years 
old and a further 35 per cent were aged between 20 and 24 years. Separating the first treatment group 
58 per cent were aged 15 to 19 and a further 33 per cent were aged between 20 and 24 years old. Thus 
eighty-nine per cent and 91 per cent respectively were the proportions in those age groups. Females 
were proportionately slightly more likely to name ecstasy than would have been expected considering 
their proportion in the population of the total treatment clients (18 per cent as against 17 per cent) and, 
if the first treatment clients are separated, in that population to a somewhat higher degree as well (21 
per cent as against 17 per cent). 
As commented on in the body of the Report, the profile of the drug misuser in the areas outside of the 
Greater Dublin area differs in some respects from his Dublin counterpart. The misuser outside Dublin 
is also most likely to be a young male, but slightly less likely to be unemployed and, particularly if 
one looks at the first treatment group separately, less likely to have left school at or before the official 
school leaving age. He will have cited cannabis as his primary drug and will have started to use his 
primary drug as a teenager. 
More than a brief look at issues in this complex area would not be possible here. Only a short 
discussion of some of the more important actions and progress being made at present will be included. 
It would be accepted that the reasons why people take drugs are multiple and complex and that 
therefore a range of strategies is needed to deal with the problems that may arise from the use and 
misuse of legal and illegal drugs. The Ministerial Task Force has published its first report on 
Measures to Reduce the Demand for Drugs( 1996) and have made a number of recommendations on 
how to address the problem in 11 priority areas, 10 in Dublin and one in Cork city. Regional 
Coordinating Committees in each Health Board area are being set up and the Ministerial Task Force 
Report (1996, pi 3) states, these committees will provide a valuable forum for joint planning between 
the various agencies and the voluntary/community sector. 
A number of research projects have been approved for funding by the National Research Support 
Fund Board and as part of a coordinated national programme to tackle the issue of drug misuse, funds 
have been made available for these projects, over a two year period, by the Minister for Commerce, 
Science and Technology, Mr Pat Rabbitte, TD. The projects which have been approved are in the 
areas of (i) analytical chemistry and detection; (ii) pharmacology and biochemistry and the third group 
of shortlisted projects come under the heading of the social sciences. 
 
In addition the Health Research Board are currently funding a two-year study – Problematic Drug Use 
and Socio-economic Disadvantage. 
In tackling the problem of demand reduction one of the actions of the Department of Health and the 
Department of Education is to aim information messages at both primary and secondary level pupils. 
Children have some knowledge of drugs, however incomplete and inaccurate, from an early age and 
some will start to use drugs while still in primary school. Indeed many young people will try drugs 
regardless of any educational intervention. However, the initiatives which have been taken by the 
Department of Health and the Department of Education, directed at young people in school, include 
the Health Promotion Unit of the Department of Health setting up a multi-media campaign aimed at 
prevention. On education, an educational package for use with post-primary students aimed at the 
development of personal and social skills for the prevention of substance abuse and entitled On My 
Own Two Feet was launched by the Minister for Education in 1994 and has been in use in post-
primary schools. A programme is being developed at the moment for use in primary schools. 
One vital component in policy-makers’ information and ability to act in responding to the problem of 
drug misuse is that reporting of treated drug misuse should be at the optimum level. If for some reason 
some organisations are unable to return data, this omission will distort the overall figures and also 
retard efforts of policy makers in obtaining the most complete picture of treated drug misuse which 
can be presented in a reporting system. 
Finally, the evidence of increasing numbers in treatment leads as always to the question as to whether 
the increases are artifacts of better reporting and a greater provision of services or if the number of 
drug misusers in the community is actually increasing? Without some estimation of overall prevalence 
on which to base the level of increase or decrease, the answer to that question must remain in the 
realms of speculation. 
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APPENDIX A 
NATIONAL DRUG TREATMENT REPORTING 
SYSTEM 
TREATMENT CENTRES 
EASTERN HEALTH BOARD 
Drug Treatment Centre 
− A statutory out-patient service providing detoxification, methadone maintenance, social, 
psychological and psychiatric assessment, urine screening, needle exchange, counselling and 
advisory service. Inpatient detoxification service attached to Beaumont Hospital. 
Community Addiction Counselling Services 
− A statutory non-prescribing service operated in the 10 Eastern Health Board Community Care 
Areas by professional workers from various health centres. Services vary from centre to centre 
but include assessment, one to one and family counselling, group therapy, prevention education, 
referral of clients, advice and support at day care level. 
Talbot Day Centre 
− A statutory community-based programme for drug free youth providing individual and group 
counselling, family therapy, prevention education, group recreational activities, parents groups 
and workshops e.g. HIV and safer sex. 
Central Addiction Service 
− A statutory agency providing a comprehensive advisory and drug treatment service including 
addiction counselling, HIV screening and counselling, outreach, prevention education, 
assessment for detoxification. 
Ushers Island Clinic and Day Centre 
− A statutory agency providing assessment and treatment for disturbed adolescents on an out-
patient basis. 
Baggot Street Clinic 
− A statutory community-based service offering harm minimisation, methadone maintenance, 
counselling, psychotherapy, detoxification programmes, GP services, rehabilitation 
programmes and other specialist services. 
Aisling Clinic 
− A statutory community-based service offering harm minimisation, methadone maintenance, 
counselling, psychotherapy, detoxification programmes, GP services, rehabilitation 
programmes and other specialist services. 
 
City Clinic 
− A statutory community-based service offering harm minimisation, methadone maintenance, 
counselling, psychotherapy, detoxification programmes, GP services, rehabilitation 
programmes and other specialist services. 
Cuan Dara 
− A statutory inpatient service offering specialised detoxification programmes from opiates and 
other drugs, counselling, psychotherapy and rehabilitation programmes. 
Coolmine Therapeutic Community 
− A voluntary non-prescribing agency providing drug free programmes, day programme – family 
and groups, prevention programme, drug and HIV counselling and support at induction, 
residential and after care level. 
Rutland Centre Limited 
− A voluntary non-prescribing agency providing assessment, counselling and therapy at 
residential and day care level. 
Ana Liffey Drug Project 
− A voluntary non-prescribing street agency with a counselling programme, prison counselling 
service, family support service, development education, literacy training, community outreach, 
peer education and support at day care level. 
Mater Dei Counselling Centre 
− A voluntary agency with a specialised counselling unit for adolescents, providing out-patient 
services, such as individual counselling, family therapy and a drama group. 
Ballymun Youth Action Project 
− A voluntary non-prescribing community based agency offering individual and family 
counselling, information on drug abuse, support for abusers and families, referral, community 
education, outreach and a range of social activities. 
Candle Community Trust 
− A community based centre for drug free young men providing support and counselling, 
personal development and training workshop facilities. 
Merchant’s Quay Project 
− A voluntary service providing one to one counselling, crisis intervention, stabilisation 
programmes, advice service to drug users affected by HIV, referral, aftercare, parents support 
group and a residential detoxification programme. 
Dublin Counselling and Therapy Centre 
− A voluntary service providing specialised counselling and group psychotherapy to individuals, 
couples and families. 
General Practitioner 
− A methadone maintenance service offered by a general practitioner based in the community. 
Probation Service, Smithfield 
− A statutory counselling and support service for clients on probation. 
St. John of God Hospital, Cluain Mhuire 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
 37 
Mountjoy Prison 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
St. Patrick’s Institution 
− A detoxification, counselling and support service. 
Arbour Hill Prison 
− A detoxification, counselling and support service. 
Wheatfield Prison 
− A detixification, counselling and support service. 
MIDLAND HEALTH BOARD 
Community Alcohol & Drugs Service 
− A statutory non-prescribing service operated in the Midland Health Board area by professional 
workers from various health centres on a day care basis. Services vary from centre to centre but 
include one to one, family, spouse and couple counselling, holistic treatments, referral, 
aftercare, outreach and various other methods depending on client need. 
MID WESTERN HEALTH BOARD 
Addiction Services 
− A statutory non-prescribing service operated in the Mid Western Health Board area by 
professional workers from various health centres and day hospitals on a day care basis. Services 
vary from centre to centre but include one to one counselling, group therapy, psychotherapy, 
relaxation and anxiety therapies, family education, self-esteem building and out-patient 
detoxification. 
Cuan Mhuire 
− A voluntary specialised residential detoxification centre, aftercare, individual counselling, 
group therapy and various rehabilitation programmes. 
Bushypark Treatment Centre 
− A voluntary service providing one to one counselling, peer education, family programmes, after 
care, relapse groups and a residential family programme. 
Limerick Prison 
A detoxification, counselling and support service. 
NORTH EASTERN HEALTH BOARD 
Addiction Services 
− A statutory non-prescribing service operated in the North Eastern Health Board area by 
professional workers from various hospitals. Services vary from centre to centre but include 
inpatient and out-patient detoxification, counselling, prevention and education. 
NORTH WESTERN HEALTH BOARD 
Addiction Services 
− A statutory non-prescribing service operated in the North Western Health Board area by 
professional workers from various health centres and hospitals at a day care level. Services vary 
from centre to centre but include counselling, group and family therapy and out-patient follow-
up. 
Alcohol and Substance Abuse Counselling 
 
− A statutory service providing assessment, one to one counselling, group therapy, family and 
concerned person support, varied treatment goals and relapse prevention. 
SOUTHERN HEALTH BOARD 
Addiction Services 
− A statutory non-prescribing service operated in the Southern Health Board area by professional 
workers from various health centres and hospitals. Services vary from centre to centre but 
include out-patient and inpatient detoxification as required, group and family counselling, 
psychiatric assessment and treatment. 
Arbour House Treatment Centre 
− A statutory service providing drug free programmes for teenagers, adolescents and adults. 
Treatment provided in form of therapy and one to one counselling backed by multi-disciplined 
professional team. 
Tabor Lodge Treatment Centre 
− A voluntary service providing individual and family counselling, education and employee 
assistance programmes and other specialist models. 
St Francis Training Centre 
− A voluntary organisation, one aspect of which is to provide residential treatment for 
adolescents. The programme includes drug counselling and support at induction, residential and 
after care level. 
SOUTH EASTERN HEALTH BOARD 
Counselling Addiction Services 
− A statutory non-prescribing service operated in the South Eastern Health Board area by 
professional workers from various health centres and hospitals offering individual, family and 
group therapy. 
C.A.T.S. – Community Alcohol Treatment Service 
− A statutory service operated in the South Eastern Health Board area. Services vary from centre 
to centre but include out-patient/in-patient detoxification, individual/family assessment and 
counselling, antabuse, concerned persons support group, education and community awareness 
programme and probation service. 
Sth. Tipperary Alcohol & Addiction Service 
− A statutory service providing assessment, detoxification, treatment and aftercare, counselling, 
individual group and family therapy advice, information and education. 
A.C.C.E.P.T. Addiction Treatment Service 
− A statutory service providing assessment, advice, information, individual counselling, group 
therapy, family support, antabuse, out-patient and in-patient detoxification. 
Aiseiri 
− A voluntary organisation with two centres covering different catchment areas. Services include 
a professional 12-step/abstinence based programme, group therapy, individual counselling, peer 
& relapse groups, out-patient family support programmes and biblio therapy. 
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WESTERN HEALTH BOARD 
Addiction Counselling Services 
− A statutory non-prescribing service operated in the Western Health Board area by professional 
workers from various health centres and hospitals. Services vary from centre to centre but 
include assessment, individual, family and group counselling, educational, preventative and 
community awareness programmes, aftercare, psychiatric consultations, outreach clinics and 
limited detoxification services. 
 
 
 
 
 
APPENDIX B 
FREQUENCY TABLES 
HEALTH BOARDS 
Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB  
   Numbers     
Type of contact 
New client 1972 131 45 40 34 15 101 10
Old client 1610 39 17 4 6 7 10 5
Not known 11 0 0 1 1 1 0 0
Ever previously treated 
Never 1396 74 31 31 28 2 20 4
Previously treated 2088 91 27 9 11 13 88 9
Not known 109 5 4 5 2 3 3 2
Table B3 
In contact with other centres 
No 2995 147 58 43 15 106 301 14
Yes 477 20 2 2 1 2 29 1
Not known 121 3 2 0 2 3 6 0
Table B4 
Resident of city/area 
Yes 3404 39 34 10 6 57 227 3
No 84 18 11 31 4 51 
TOTAL TREATMENT CONTACTS 
Table Bl 
260 
75 
1 
Table B2 
203 
127 
6 
36
4
1
101
68 102 11
Not known 105 1 5 0 0l 8 3 7 1
Table B5 
Area of Residence 
North Inner City 599 – – – – – – – –
South Inner City 423 – – – – – – –
Remainder Nth. City 962 – – – – – – – –
Remainder Sth. City 1380 – – – – – – – –
GDA unspecified 228 – – – – – – – –
Great Britain 1 – – – – – – – –
–
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Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB  
   Numbers     
Table B6 
Nation of origin 
Ireland 3563 169 55 44 41 17 111 333 14
UK 19 1 3 1 0 1 0 1 1
Italy 5 0 0 0 0 0 0 0 0
Spain 2 0 0 0 0 0 0 0 0
Iran 1 0 0 0 0 0 0 0 0
USA 1 0 1 0 0 0 0 0 0
Switzerland 2 0 0 0 0 0 0 0 0
France 0 0 0 0 0 0 0 2 0
Not known 0 0 3 0 0 0 0 0 0
Table B7 
Last treated, if previously treated 
Ongoing 205 3 0 0 1 0 2 32 0
Two years of less 857 35 19 7 4 1 11 65 5
Four years or less 108 2 2 1 0 1 1 8 1
Over four years 53 2 0 0 0 0 0 2 1
Never treated 1396 91 31 31 28 13 88 203 4
Not known 974 37 10 6 8 3 9 26 4
Table B8 
Gender 
Male 2785 133 48 35 37 10 102 281 10
Female 787 37 12 10 4 7 9 54 5
Not known 21 0 2 0 0 1 0 1 0
Table B 9 
Age 
<15 years 37 1 3 0 0 0 30 13 0
15-19 years 1059 56 15 20 15 6 45 145 0
20-24 years 1212 54 16 12 15 6 19 90 5
25-29 years 648 27 5 10 4 1 10 33 1
30-35 years 396 19 7 3 0 1 6 14 1
35 years+ 229 12 15 0 4 3 1 38 8
Not known 12 1 1 0 3 1 0 3 0
Table B10 
Living status 
Parental family 2362 132 28 30 25 10 65 2145 
Partner 541 17 16 4 7 4 21 33 6
Institution/Homeless 118 2 3 1 1 1 4 140 
Friends 63 4 2 1 2 1 5 16 0
Alone 151 6 6 7 3 0 9 23 2
Lone parent 49 2 1 0 0 1 2 3 1
Other 52 1 0 0 2 0 1 10 0
Not known 257 6 6 2 1 1 4 23 1
Table B11 
Age left school 
<15 years 1048 32 10 7 8 3 18 22 5
15 years 1030 33 5 8 8 4 24 43 0
16 years+ 1145 77 26 20 18 9 45 91 7
Still at school 98 13 6 3 3 1 6 50 0
Not known 272 15 15 7 4 1 18 130 3
Erratum 
In Table B10 Living Status figures should read 
Parental Family                  SHB (214) WHB (5) 
Institution/Homeless                  SHB (14) WHB (0) 
 
Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB  
   Numbers     
Table B12 
Employment status 
Unemployed/Casual 3082 128 40 35 28 9 72 181 10
Regular employment 346 25 7 4 7 7 27 62 4
Other 107 15 8 4 5 1 9 71 0
Not known 58 2 7 2 1 1 3 22 1
Table B13 
Primary drug 
Opiate 3112 100 12 4 10 4 6 23 2
Cannabis 238 34 31 21 11 6 76 154 3
Stimulants 128 25 11 14 19 6 19 106 3
Hypnotics/Sedatives 64 4 5 0 0 1 3 33 6
Hallucinogens 28 5 0 4 1 0 3 14 1
Volatile Inhalants 13 1 3 2 0 0 3 5 0
Other 4 1 0 0 0 1 1 1 0
Not known 6 0 0 0 0 0 0 0 0
Table B14 
Age first used 
<15 years 281 18 6 10 10 0 21 76 0
15-19 years 2136 99 32 20 17 13 55 173 5
20-24 years 656 26 10 7 11 1 14 40 4
25 years+ 259 19 5 3 0 3 8 34 5
Not known 261 8 9 5 3 1 13 13 1
Table B15 
Frequency in past month 
Drug free 439 20 18 5 8 3 17 22 0
Once weekly 236 16 5 3 2 4 11 134 1
2-6 times weekly 423 36 27 12 13 7 31 129 6
Daily 2342 89 5 22 16 3 45 29 7
Not known 153 9 7 3 2 1 7 22 1
Table B16 
Route of administration 
Inject 1891 60 9 3 5 1 2 14 2
Smoke 1255 69 30 23 16 8 75 156 3
Eat/Drink 383 37 19 17 19 8 28 157 8
Sniff 25 3 4 2 1 0 5 8 1
Not known 39 1 0 0 0 1 1 1 1
Table B17 
Duration of use 
1 year or less 756 37 14 6 7 4 13 79 0
2-3 years 1213 52 13 16 18 5 37 109 4
4-5 years 483 27 7 9 7 2 13 54 4
6-9 years 330 19 5 8 1 2 18 35 0
10 years+ 501 21 11 1 3 2 12 38 5
Not known 310 14 12 5 5 3 18 21 2
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Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB  
   Numbers     
Table B18 
Secondary Drug (1) 
None 523 25 18 15 2 5 15 27 3
Opiate 1223 23 2 1 2 2 2 6 2
Cannabis 572 43 9 11 13 2 17 77 1
Stimulants 316 33 6 6 11 1 27 73 1
Hallucinogens 45 6 10 12 3 7 26 37 2
Hypnotics/Sedatives 552 9 3 0 2 0 2 17 2
Alcohol 100 13 12 0 2 1 15 96 4
Other 14 18 2.. 0 1 0 6 3 0
Table B19 
Secondary drug (2) 
None 1500 68 42 25 8 8 45 123 9
Opiate 352 5 0 1 3 0 1 6 1
Cannabis 405 16 4 3 8 3 6 33 2
Stimulants 225 14 4 8 6 1 25 42 1
Hallucinogens 42 6 3 3 4 3 19 51 0
Hypnotics/Sedatives 479 15 2 0 1 1 2 8 1
Alcohol 81 8 5 3 2 2 7 64 1
Other 0 38 0 0 1 0 0 4 0
Not known 509 0 2 5 8 0 6 5 0
Table B20 
Age first used any drug 
< 15 years 1075 46 8 12 17 0 25 138 1
15-19 years 1691 88 34 20 12 12 56 144 9
20-24 years 191 15 5 6 6 1 9 11 1
25 years+ 66 6 2 0 0 2. 5 20 3
Not known 570 15 13 7 6 3 16 23 1
Table B21 
Currently injecting 
Yes 1330 43 5 2 3 0 3 9 1
No 2045 122 57 42 38 18 105 311 13
Not known 218 5 0 1 0 0 3 16 1
Table B22 
Currently sharing 
Yes 288 15 0 1 0 0 2 3 1
No 1637 19 4 0 3 0 1 3 13
Not known 580 14 1 2 0 0 3 19 1
Not applicable 1088 122 57 42 38 18 105 311 0
 
 
FIRST TREATMENT CONTACTS 
Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB 
   Numbers     
Table B1A 
Type of contact 
New client 1396 91 31 31 28 13 88 203 4
Old client 0 0 0 0 0 0 0 0 0
Not known 0 0 0 0 0 0 0 0 0
Table B2A 
Resident of city/area 
Yes 1313 47 21 24 7 5 46 146 3
No 44 44 7 7 21 1 40 55 0
Not known 39 0 3 0 0 7 2 2 1
Table B3A 
Area of residence 
North In City 187 – – – – – – – –
South In City 142 – – – – – – – –
Rem. N. City 368 – – – – – – – –
Rem. S. City 618 – – – – – – – –
GDA unspec 81 – – – – – – – –
Table B4A 
Nation of origin 
Ireland 1382 90 27 31 28 12 88 200 3
UK 8 1 1 0 0 1 0 1 1
Italy 3 0 0 0 0 0 0 0 0
Spain 1 0 0 0 0 0 0 0 0
Iran 1 0 0 0 0 0 0 0 0
USA 1 0 1 0 0 0 0 0 0
Switzerland 0 0 0 0 0 0 0 0 0
France 0 0 0 0 0 0 0 2 0
Not known 0 0 2 0 0 0 0 0 0
Table B5A 
Last treated, if prev. treated 
Ongoing 0 0 0 0 0 0 0 0 0
Two years of less 0 0 0 0 0 0 0 0 0
Four years or less 0 0 0 0 0 0 0 0 0
Over four years 0 0 0 0 0 0 0 0 0
Never treated 1396 91 31 0 28 13 88 203 4
Table B6A 
Gender 
Male 1092 67 22 25 24 6 83 173 3
Female 297 24 8 6 4 6 5 30 1
Not known 7 0 1 0 0 1 0 0 0
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Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB 
   Numbers     
Table B 7A 
Age 
<15 years 30 1 3 0 0 0 0 12 0
15-19 years 652 45 14 16 10 5 24 98 0
20-24 years 487 25 8 7 14 2 39 49 2
25-29 years 141 8 4 6 2 1 17 19 1
30-35 years 56 5 1 2 0 1 5 5 0
35 years+ 27 7 1 0 1 3 2 20 1
Not known 3 0 0 0 1 1 1 0 0
Table B8A 
Living status 
Parental family 1073 74 19 23 17 6 58 142 1
Partner 119 8 6 2 5 4 11 17 1
Inst/Homeless 37 0 1 0 0 1 3 8 0
Friends 21 2 1 1 2 1 3 6 0
Alone 41 2 1 4 3 0 7 13 1
Lone parent 12 0 0 0 0 1 2 2 1
Other 19 1 0 0 1 0 0 7 0
Not known 74 4 3 1 0 0 4 8 0
Table B9A 
Age left school 
<15 years 349 13 6 5 3 2 12 7 2
15 years 399 17 0 6 6 3 17 21 0
16 years+ 480 43 14 14 14 6 41 42 1
Still at school 77 11 6 2 3 1 6 46 0
Not known 91 7 5 4 2 1 12 87 1
Table B10A 
Employment status 
Unemployed/Casual 1100 60 16 25 20 6 55 92 4
Regular employment 187 17 4 3 5 5 22 38 0
Other 83 13 8 2 3 1 9 61 0
Not known 26 1 3 1 0 1 2 12 0
Table B11A 
Primary drug 
Opiate 1075 40 2 3 7 2 0 5 1
Cannabis 174 25 17 14 5 5 68 110 2
Stimulants 98 18 9 12 16 4 14 59 0
Hypnotics/Sedatives 16 3 0 0 0 1 0 15 1
Hallucinogens 16 4 0 2 0 0 3 10 0
Volatile Inhalants 10 0 3 0 0 0 3 4 0
Other 3 1 0 0 0 1 0 0 0
Not known 4 0 0 0 0 0 0 0 0
Table B12A 
Age first used 
<15 years 128 13 4 6 4 0 16 49 0
15-19 years 895 54 20 13 14 9 47 112 2
20-24 years 220 11 3 5 9 0 13 16 0
25 years+ 74 9 0 2 0 3 2 17 2
Not known 79 4 4 5 1 1 10 9 0
 
Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB 
   Numbers     
Table B13A 
Frequency in past month 
Drug free 125 14 5 2 7 2 17 13 0
Once weekly 100 23 4 3 0 2 10 16 1
2-6 times weekly 245 40 20 10 11 5 23 94 2
Daily 892 10 1 15 10 3 35 71 1
Not known 34 4 1 1 0 1 3 9 0
Table B14A 
Route of administration 
Inject 415 17 2 1 3 1 0 2 1
Smoke 785 47 16 16 9 5 66 111 2
Eat/Drink 167 27 10 14 15 7 18 86 1
Sniff 19 0 3 0 1 0 4 4 0
Not known 10 0 0 0 0 0 0 0 0
Table B15A 
Duration of use 
1 yr or less 492 28 14 4 7 2 11 61 0
2-3 years 561 32 7 13 14 4 30 60 0
4-5 years 139 8 4 5 4 0 9 26 4
6-9 years 54 8 1 4 0 2 15 20 0
10 years+ 45 6 0 0 0 2 9 22 0
Not known 105 9 5 0 3 3 14 14 0
Table B16A 
Secondary Drug(1) 
None 238 13 14 11 2 4 15 19 1
Opiate 368 5 0 1 2 0 0 0 1
Cannabis 293 22 4 7 8 1 12 49 0
Stimulants 165 24 4 3 7 0 21 37 1
Hallucinogens 26 3 2 9 3 7 22 18 0
Hypnotics/Sedatives 138 1 1 0 1 0 0 8 0
Alcohol 48 9 4 0 1 1 13 69 1
Other 4 14 1 0 1 0 0 1 0
Not known 111 0 1 0 3 0 5 2 0
Table B17A 
Secondary drug (2) 
None 549 39 25 19 6 7 38 83 2
Opiate 108 3 0 0 2 0 1 1 0
Cannabis 171 6 0 3 7 2 4 13 1
Stimulants 113 6 2 4 3 1 19 25 0
Hallucinogens 25 1 1 2 3 2 14 31 0
Hypnotics/Sedatives 172 6 0 0 0 0 0 4 1
Alcohol 37 3 2 3 1 1 5 44 0
Volatile inhalants 2 0 0 0 0 0 1 0 0
Other 9 27 0 0 1 0 0 0
Not known 210 0 1 0 5 0 2 0
0 
6 
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Dublin Rest of 
EHB 
MEHB MWHB NEHB NWHB SEHB SHB WHB 
  Numbers     
Table B18A 
Age first used any drug 
<15 years 434 23 4 8 10 0 19 77 1
15-19 years 686 52 21 12 12 9 48 101 2
20-24 years 57 8 2 4 4 0 8 5 0
25 years + 17 2 0 0 0 2 2 11 1
Not known 202 6 4 7 2 2 11 9 0
Table B19A 
Currently injecting 
Yes 336 12 1 1 2 0 0 0 1
No 991 76 30 29 26 13 86 195 3
Not known 69 3 0 1 0 0 2 8 0
Table B20A 
Currently sharing 
Yes 63 4 0 0 0 0 0 0 0
No 211 6 1 0 2 0 0 0 1
Not appl. 991 76 30 29 26 13 86 195 3
Not known 131 5 0 2 0 0 2 8 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX C 
Population of the Greater Dublin Area 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
112769 106825 219594
51.4 48.6 100.0
Under 15 years 
25.8 22.4 24.0
43446 43882 87328
49.8 50.2 100.0
15-19 years 
9.9 9.2 9.5
43232 46168 89400
48.4 51.6 100.0
20-24 years 
9.9 9.7 9.8
36418 40130 76548
47.6 52.4 100.0
25-29 years 
8.3 8.4 8.4
32927 35454 68381
48.2 51.8 100.0
30-34 years 
7.5 7.4 7.5
29236 31931 61167
47.8 52.2 100.0
35-39 years 
6.7 6.7 6.7
27397 29154 56551
48.4 51.6 100.0
40-44 years 
6.3 6.1 6.2
112364 144183 256547
43.8 56.2 100.0
45+years 
25.7 30.2 28.0
All ages 437789 477727 915516
Total Row: per cent 47.8 52.2 100.0
Total Column: per cent 100.0 100.0 100.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 49 
Population of the Remainder Eastern Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
50041 46913 96954
51.6 48.4 100.0
Under 15 years 
30.3 28.5 29.4
17158 15853 33011
52.0 48.0 100.0
15-19 years 
10.4 9.6 10.0
11742 11228 22970
51.1 48.9 100.0
20-24 years 
7.1 6.8 7.1
11516 12266 23782
48.4 51.6 100.0
25-29 years 
7.0 7.4 7.2
12733 13200 25933
49.1 50.1 100.0
30-34 years 
7.7 8.0 7.7
12350 12748 25098
49.2 50.3 100.0
35-39 years 
7.5 7.7 7.6
12088 12028 24116
50.1 49.9 100.0
40-44 years 
7.3 7.3 7.3
37298 40547 77845
47.9 52.1 100.0
45+years 
22.7 24.7 23.7
All ages 164926 164783 329709
Total Row: per cent 50.3 49.7 100.0
Total Column: per cent 100.0 100.0 100.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Population of the Midland Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
29697 28182 57879
51.3 48.7 100.0
Under 15 years 
28.7 28.3 28.5
10117 9196 19313
52.4 47.6 100.0
15-19 years 
9.8 9.2 9.5
7180 6051 13231
54.3 45.7 100.0
20-24 years 
6.9 6.1 6.5
6562 6400 12962
50.6 49.4 100.0
25-29 years 
6.4 6.4 6.4
7031 6825 13856
50.7 49.3 100.0
30-34 years 
6.8 6.9 6.8
6883 6599 13482
51.0 49.0 100.0
35-39 years 
6.7 6.6 6.7
6319 6051 12370
51.0 49.0 100.0
40-44 years 
6.1 6.1 6.1
29555 30336 59891
49.3 50.7 100.0
45+years 
28.6 30.4 29.5
All ages 103344 99640 202984
Total Row: per cent 51.0 49.0 100.0
Total Column: per cent 100.0 100.0 100.0
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Population of the Mid Western Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
43108 41028 84136
51.2 48.8 100.0
Under 15 years 
27.5 26.7 27.1
15345 14653 29998
51.2 48.8 100.0
15-19 years 
9.8 9.5 9.6
11425 10091 21516
53.1 46.9 100.0
20-24 years 
7.3 6.6 6.9
9976 9982 19958
50.0 50.0 100.0
25-29 years 
6.4 6.5 6.4
10886 10456 21342
51.0 49.0 100.0
30-34 years 
6.9 6.8 6.9
10685 10306 20991
50.9 49.1 100.0
35-39 years 
6.8 6.7 6.8
10380 10022 20402
50.8 49.2 100.0
40-44 years 
6.6 6.5 6.6
45011 47374 92385
48.7 51.3 100.0
45+years 
287 30.7 29.7
All ages 156816 310728
Total Row: per cent 50.5 49.5 100.0
Total Column: per cent 100.0 100.0 100.0
153912
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Population of the North Eastern Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
44220 42136 86356
51.2 48.8 100.0
Under 15 years 
29.2 28.4 28.8
14680 13528 28208
52.0 48.0 100.0
15-19 years 
9.7 9.1 9.4
10496 9224 19720
53.2 46.8 100.0
20-24 years 
6.9 6.2 6.6
9661 9735 19396
49.8 50.2 100.0
25-29 years 
6.4 6.6 6.5
10335 10463 20798
50.3 100.0
30-34 years 
6.8 7.0 6.9
10559 20600
51.2 48.8 100.0
35-39 years 
6.9 6.8 6.9
10031 9570 19601
51.2 48.8 100.0
40-44 years 
6.6 6.4
41658 43846 85504
48.7 51.3 100.0
45+years 
27.5 29.5 28.4
All ages 151640 148543 300183
Total Row: per cent 50.5 49.5 100.0
Total Column: per cent 100.0 100.0 100.0
49.7
10041
6.5
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Population of the North Western Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
29502 27901 57403
51.4 48.6 100.0
Under 15 years 
28.0 27.1 27.6
9673 9445 19118
50.6 49.4 100.0
15-19 years 
9.2 9.2
6764 6205 12951
52.0 48.0 100.0
20-24 years 
6..4 6.0 6.2
5948 6095 12043
49.4 50.6 100.0
25-29 years 
5.7 5.9 5.8
6550 6677 13227
49.5 50.5 100.0
30-34 years 
6.2 6.5 6.4
6659 6542 13201
50.4 49.6 100.0
6.3 6.3 6.3
6719 6379 13098
51.3 48.7 100.0
40-44 years 
6.4 6.3 6.3
33471 33662 67133
49.8 50.2 100.0
45+years 
31.8 32.7 32.2
All ages 105268 102906 208174
Total Row: per cent 50.6 49.4 100.0
Total Column: per cent 100.0 100.0 100.0
9.2
35-39 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Population of the South Eastern Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
54557 51740 106297
51.3 48.7 100.0
Under 15 years 
28.2 27.3 27.7
18779 17187 35966
52.2 47.8 100.0
15-19 years 
9.7 9.1 9.5
13892 12219 26111
53.2 46.8 100.0
20-24 years 
7.2 6.4 6.8
12855 12926 25781
49.9 50.1 100.0
25-29 years 
6.6 6.8 6.7
13226 13214 26440
50.0 50.0 100.0
30-34 years 
6.8 7.0 6.9
12949 25382
51.0 49.0 100.0
35-39 years 
6.7 6.6 6.6
12375 11666 24041
51.5 48.5 100.0
40-44 years 
6.5 6.1 6.3
54848 58322 113170
48.5 51.5 100.0
45+years 
28.3 30.7 29.5
All ages 193481 189707 383188
Total Row: per cent 50.5 49.5 100.0
Total Column: per cent 100.0 100.0 100.0
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Population of the Southern Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
71482 68071 139553
51.2 48.8 100.0
Under 15 years 
26.8 25.6 26.2
25784 24118 49902
51.7 100.0
15-19 years 
9.8 9.0 9.4
20267 18498 38765
52.3 47.7 100.0
20-24 years 
7.6 7.0 7.3
18105 18172 36277
50.0 50.0 100.0
25-29 years 
6.8 6.8 6.8
18312 18267 36579
50.1 49.9 100.0
30-34 years 
6.9 6.9 6.9
17976 17521 35497
50.6 49.4 100.0
35-39 years 
6.7 6.6 6.7
17444 16732 34176
51.0 49.0 100.0
40-44 years 
6.5 6.4
77104 84410 161514
47.7 52.3 100.0
45+years 
28.9 31.8 30.3
All ages 266474 265789 532263
Total Row: per cent 50.1 49.9 100.0
Total Column: per cent 100.0 100.0 100.0
48.3
6.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Population of the Western Health Board 1991 
Age and Sex (Number, Row per cent and Column per cent) 
 Male Female Total 
474 44940 924402
51.4 48.6 100.0
Under 15 years 
27.3 26.5 26.9
16426 15756 32182
51.0 49.0 100.0
15-19 years 
9.5 9.3 9.4
11499 10409 21908
52.5 47.5 100.0
20-24 years 
6.6 6.2 6.4
9619 9955 19574
49.1 50.9 100.0
25-29 years 
5.5 5.9 5.7
11168 11347 22515
49.6 50.4 100.0
30-34 years 
6.4 6.7 6.6
11427 11044 22471
50.9 49.1 100.0
35-39 years 
6.6 6.5 6.6
11103 10225 21328
52.1 47.9 100.0
40-44 years 
6.0 6.2
54976 55618 440594
49.7 100.0
45+years 
31.7 32.9 32.2
All ages 173680 169294 342974
Total Row: per cent 50.6 49.4 100.0
Total Column: per cent 100.0 100.0 100.0
6.4
50.3
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APPENDIX D 
ESTIMATION OF RATES FOR TREATED DRUG MISUSE 
Rates were per ‘000 population aged between 15 and 39, based on 1991 Census of Population 
. 
GREATER DUBLIN AREA 
Total Treatment Contacts 
Total Treatment Contacts 
Number 3399 
Rate 8.9 
REMAINDER EASTERN HEALTH 
Total Treatment Contacts 
Number 164 
Rate 1.3 
MIDLAND HEALTH BOARD 
Total Treatment Contacts 
Number 61 
Rate 0.8 
MID WESTERN HEALTH BOARD 
Total Treatment Contacts 
Number 44 
Rate 0.4 
NORTH EASTERN HEALTH BOARD 
Total Treatment Contacts 
Number 40 
Rate 0.4 
NORTH WESTERN HEALTH BOARD 
Total Treatment Contacts 
Number 17 
Rate 0.2 
SOUTH EASTERN HEALTH BOARD 
Number 109 
Rate 0.8 
SOUTHERN HEALTH BOARD 
Total Treatment Contacts 
Number 322 
Rate 1.6 
WESTERN HEALTH BOARD 
Total Treatment Contacts 
Number 9 
Rate 0.08 
 
 
 
First Treatment Contact 
Number 1396 
Rate 3.6 
First Treatment Contact 
Number 91 
Rate 0.7 
First Treatment Contact 
Number 31 
Rate 0.4 
First Treatment Contact 
Number 31 
Rate 0.3 
First Treatment Contact 
Number 28 
Rate 0.3 
First Treatment Contact 
Number 13 
Rate 0.2 
First Treatment Contact 
Number 88 
Rate 0.6 
First Treatment Contact 
Number 203 
Rate 1.0 
First Treatment Contact 
Number 4 
Rate 0.03 
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APPENDIX E 
IRELAND – DRUG TREATMENT REPORTING SYSTEM 
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